ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,192, issued on Dec. 2, was assigned to CELLIS AG (Zurich).
"Cellular targeted label delivery system" was invented by Magdalena Krol (Warsaw, Poland), Irene Benni (Rome), Paola Baiocco (Rome), Tomasz Rygiel (Warsaw, Poland) and Alberto Boffi (Rome).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an isolated cellular targeted delivery system comprising a CD45+ leukocyte cell comprising within said cell a complex of one or more iron binding proteins and/or a label as well as methods for producing such isolated cellular targeted delivery system and uses of such system for therapy diagnosis and in particular for diagnosis of...